Article Text
Therapeutics
Combination ACE inhibitor and angiotensin receptor blocker therapy was better than monotherapy in non-diabetic renal disease
Statistics from Altmetric.com
Footnotes
-
Source of funding: in part, Ministry of Health, Labour, and Welfare, Japan.
-
For correspondence: Dr N Nakao, Showa University, Yokohama, Japan. lancetjp{at}yahoo.co.jp
-
Abstract and commentary also appear in ACP Journal Club.